| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.06 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |